Modelo de Atención Integral de Salud para el Sistema Nacional Integrado de Salud / Comprehensive Health Care Model for the National Integrated System of Health

El Ministerio de Salud, en su calidad de Autoridad Sanitaria Nacional y rector del Sistema Nacional Integrado de Salud (SNIS), creado mediante el Decreto Legislativo N° 302, de fecha dos de mayo de dos mil diecinueve, publicado en el Diario Oficial N° 89, tomo 423, del 17 de mayo de 2019; presenta el Modelo de Atención Integral de Salud, como una de las medidas fundamentales del proceso de establecimiento de los principios y normas generales para la organización y funcionamiento del SNIS, que permita transitar progresivamente hacia el acceso universal a la salud y cobertura universal en forma equitativa, oportuna y de calidad para la población en los diferentes niveles de atención. Por tanto, se insta a todos los miembros integrantes y colaboradores del SNIS a realizar todas las acciones pertinentes que faciliten la adopción del Modelo de Atención Integral de Salud, con prioridad en lo relativo a la reforma de sus marcos jurídicos y la asignación y aplicación de los recursos presupuestarios requeridos, tal como lo establece la Ley del Sistema Nacional Integrado de Salud

The Ministry of Health, in its capacity as National Health Authority and rector of the National Integrated Health System (SNIS), created by Legislative Decree No. 302, dated May 2, two thousand and nineteen, published in the Official Gazette No. 89, volume 423, of May 17, 2019; presents the Comprehensive Health Care Model, as one of the fundamental measures in the process of establishing the general principles and standards for the organization and operation of the SNIS, which allows progressive transition towards universal access to health and universal coverage in an equitable manner , timely and quality for the population at different levels of care. Therefore, all members and collaborators of the SNIS are urged to carry out all pertinent actions that facilitate the adoption of the Comprehensive Health Care Model, with priority in relation to the reform of their legal frameworks and the allocation and application of the required budgetary resources, as established by the Law of the National Integrated Health System

Determinantes sociales que influyen en el acceso en Chile al Plan GES, según CASEN 2017 / Social determinants of access to the explicit guarantees health program implemented in Chile

BACKGROUND: In Chile, an eventual implementation of a plan with universal health coverage is a challenge. The already implemented explicit health guarantees plan (GES) could be a benchmark. For this reason, it is important to obtain information about the results of its implementation. AIM: To identify the social determinants of health that influence the access to GES. MATERIAL AND METHODS: The National Socioeconomic Characterization Survey performed in 2017 was used as a data source. The beneficiaries of 20 diseases covered by GES and inquired in the survey were considered for the present study. RESULTS: People with the higher probability of access to GES plan belong to the lowest income quintiles, are nationals, live in the central-southern metropolitan Santiago, have lower education, have a public health insurance program (FONASA) and are aged mostly over 60 years. The diseases with the highest probability of access to the program are primary arterial hypertension, type 1 and type 2 diabetes mellitus, acute myocardial infarction, moderate and severe bronchial asthma, breast cancer, colon cancer, and bipolar disorder. CONCLUSIONS: The access probability to the GES program is in line with the epidemiological profile of the Chilean population, and with a greater social vulnerability.

Atlas des statistiques sanitaires africaines 2022: analyse de la situation sanitaire de la Région africaine ­ rapport de synthèse

NA

WHO global strategy on digital health and its implications to China / 中华预防医学杂志

The World Health Organization (WHO) released the global strategy report on digital health (2020-2025) in Geneva in 2019, which established the priority of the digital health strategy and formulated strategic objectives, guiding principles, action framework and implementation plans to promote the development of global digital health, and to achieve universal health coverage and the health-related sustainable development goals. Despite China's rapid development in the field of digital health, there is still a big gap between the realization of the goal of digital health. Therefore, it is urgent to grasp the major historical opportunity and step into a new era of digital health with the support of digital technology platform.

Prevalence and Demographic Characteristics of Prostate Cancer Patients in Colombia: data from the National Health Registry from 2015 to 2019 / Prevalencia y características demográficas de pacientes con cáncer de próstata en Colombia: datos del Registro de Salud Nacional de 2015 a 2019

Background and Objective Prostate cancer is a multifactorial disease and is among the top five causes of death in men worldwide. The Colombian Ministry of Health has adopted the Integrated Information System on Social Protection (Sistema Integrado de Información de la Protección Social, SISPRO, by its Spanish acronym) registry to collect comprehensive information from the Colombian health system. The system provides close to universal coverage (around 95%). We aimed to establish the prevalence of prostate cancer in Colombia and to describe its demographics, based on data provided by SISPRO, openly available for scientific analysis. Methods Using the SISPRO data from 2015 through 2019, we analyzed the prevalence and demographic characteristics of patients diagnosed with prostate cancer. Results We identified a total of 43,862 patients with prostate cancer in the 5-year period and estimated a prevalence of 4.54 cases per 1,000 habitants, using as denominator males over 35 years old. We calculated a prevalence of early-onset prostate cancer (i.e., 35­54 years) of 0.14 per 1,000 habitants (791 cases in 5 years). The highest prevalence was observed in patients>80 years (33.45 per 1,000 habitants). The departments with the highest prevalence were Bogotá, Valle del Cauca, Risaralda, and Boyacá, and the region with the lowest prevalence was Amazonas.

Antecedentes y Objetivo El cáncer de próstata es una enfermedad multifactorial, y se encuentra entre las cinco principales causas de muerte en hombres a nivel mundial. El Ministerio de Salud de Colombia ha adoptado el Sistema Integrado de Información de la Protección Social (SISPRO) para la recopilación de la información integral del sistema de salud colombiano. El sistema proporciona una cobertura casi universal (alrededor del 95%). El objetivo de este estudio fue establecer la prevalencia del cáncer de próstata en Colombia y describir su demografía, con base en los datos proporcionados por el SISPRO, disponibles de forma abierta para el análisis científico. Métodos Utilizando los datos del SISPRO de 2015 a 2019, se analizaron la prevalencia y las características demográficas de los pacientes diagnosticados con cáncer de próstata. Resultados Se identificó un total de 43,862 pacientes con cáncer de próstata en el período de 5 años, con una prevalencia de 4,54 casos por cada mil habitantes, utilizando como denominador hombres mayores de 35 años. La prevalencia de cáncer de próstata de inicio temprano (es decir, paciente de 35 a 54 años) fue de 0.14 por mil habitantes (791 casos en 5 años). La mayor prevalencia se observó en pacientes > 80 años (33,45 por mil habitantes). Los departamentos con mayor prevalencia fueron Bogotá, Valle del Cauca, Risaralda, y Boyacá. Y la región con menor prevalencia fue Amazonas. Conclusión Describimos la prevalencia y la demografía del cáncer de próstata y el cáncer de próstata de inicio temprano en Colombia utilizando la base de datos del sistema nacional de salud. Observamos una distribución desigual de la prevalencia entre las regiones, que puede estar relacionada con factores raciales, ambientales, o de acceso, que justifican más estudios.

Historia de la seguridad social en el Perú: 1936 - 2021 / History of social security in Peru: 1936 - 2021

En estos 200 años de Independencia del Perú, el Seguro Social de Salud ­ EsSalud celebra sus 85 años de gestión institucional, realizando una cobertura de prestaciones de salud, económicas y sociales a más de 11 millones de asegurados, asumiendo un reto difícil y delicado por la actual pandemia que nos ha llevado a replantear nuevas estrategias de gestión y coordinación con otras entidades públicas y privadas, así como fortalecer nuestras buenas prácticas institucionales que nos permitan cumplir el objetivo de servir a nuestros asegurados y a la sociedad peruana. A lo largo de nuestra historia las diferentes gestiones han identificados sus fortalezas, oportunidades, debilidades y amenazas, las cuales han exigido renovar y establecer nuevos mecanismos y políticas institucionales para mejorar y modernizar la seguridad social, como lo fue en su momento la contratación de personal administrativo y asistencial; construcción de hospitales; funcionamiento de escuelas de enfermeras, nutricionistas, laboratoristas; construcción de viviendas; otorgamiento de préstamos hipotecarios; cobertura de prestaciones pensionarias; protección con subsidios; funcionamiento de centros de adulto mayor, rehabilitación profesional y social, medicina complementaria, centros de salud especializados y otros hasta nuestras actuales funciones misionales. Es en este contexto, que nos satisface presentar este resumen de nuestra historia institucional para que la sociedad y las futuras generaciones conozcan de la importancia social que hemos desarrollado a lo largo de éstas décadas, así como para fortalecer nuestra identidad institucional en nuestros asegurados, funcionarios, servidores y personal de apoyo que día a día escriben la historia de la seguridad social en el Perú

Measuring geospatial healthcare access to primary level facilities in Mexico: a GIS-based diagnosis analysis / Medindo o acesso geoespacial da assistência médica a instalações de nível primário no México: uma análise de diagnóstico baseada em sistemas de informação geográfica

Abstract To describe a general overview of health services delivery in Mexico and geospatially analyze the current distribution and accessibility of Primary Health Care (PHC) facilities to contribute to new approaches to improve healthcare planning in Mexico. We performed a spatial analysis of official data to analyze current distances from health facilities to population, to determine the underserved areas of health services delivery in three selected states using a ranking of indicators. We estimated service area coverage of PHC facilities with road networks of three Mexican states (Chiapas, Guerrero, and Oaxaca). Our estimations provide an overview of spatial access to healthcare of the Mexican population in Mexico's three most impoverished states. We did not consider social security nor private providers. Geospatial access to health facilities is critical to achieving PHC and adequate coverage. Countries like Mexico must measure this to identify underserved areas with a lack of geospatial access to healthcare to solve it. This type of analysis provides critical information to help decision-makers decide where to build new health facilities to increase effective geospatial access to care and to achieve Universal Health Coverage.

Resumo Descrever uma visão geral da prestação de serviços de saúde no México e analisar geoespacialmente a atual distribuição e acessibilidade das unidades de APS para contribuir com novas abordagens para melhorar o planejamento da saúde no México. Realizamos uma análise espacial de dados oficiais para analisar as distâncias atuais das unidades de saúde à população, para determinar as áreas descobertas de prestação de serviços de saúde em 3 estados selecionados usando uma classificação de indicadores. Estimamos a cobertura da área de serviço das unidades de APS com redes viárias de 3 estados do México (Chiapas, Guerrero e Oaxaca). Nossas estimativas fornecem uma visão geral do acesso espacial à saúde da população mexicana nos três estados mais pobres do México. Não consideramos seguridade social nem prestadores privados. O acesso geoespacial às unidades de saúde é fundamental para alcançar a cobertura universal de saúde e uma cobertura eficaz. Países, como o México, devem medir isso para identificar áreas não merecidas com falta de acesso geoespacial à saúde para resolvê-lo. Os governos devem gerar políticas e mecanismos para distribuir efetivamente novas instalações de saúde para aumentar o acesso geoespacial efetivo à saúde, bem como para evitar instalações de saúde não planejadas.

Atenção à saúde da mulher durante a pandemia COVID-19: orientações para o trabalho na APS / Women's health care during COVID-19 pandemic: a guide for primary health care / Atención a la salud de la mujer durante la pandemia de COVID-19: pautas para el trabajo de APS

A pandemia pelo novo coronavírus causou uma crise sanitária mundial, com repercussões mais graves em sistemas de saúde já sobrecarregados e em sociedades mais desiguais. Neste artigo, revisou-se a literatura sobre pontos importantes no atendimento à saúde da mulher durante pandemias nos serviços de Atenção Primária à Saúde (APS). Destaca-se o papel crucial da APS na prevenção de iniquidades. No tocante à saúde da mulher, é importante o foco na atuação contra a violência doméstica, manutenção de atenção ao ciclo gravídico-puerperal, contracepção e condições potencialmente graves, como Infecções Sexualmente Transmissíveis e seguimento oncológico.

The new coronavirus pandemic caused a global health crisis, with more serious repercussions on already overburdened health systems and more unequal societies. In this article, the literature about important points in women's health care during pandemics in Primary Health Care (PHC) services was reviewed. PHC's crucial role in preventing inequities is highlighted. With regard to women's health, it is important to focus on actions against domestic violence, maintaining attention to the pregnancy-puerperal cycle, contraception and potentially serious conditions, such as Sexually Transmitted Infections and oncological follow-up.

La nueva pandemia de coronavirus causó una crisis de salud global, con repercusiones más serias en los sistemas de salud ya sobrecargados y en sociedades más desiguales. En este artículo, revisamos la literatura sobre puntos importantes en el cuidado de la salud de las mujeres durante las pandemias en los servicios de Atención Primaria de Salud (APS). Se destaca el papel crucial de APS en la prevención de las inequidades. Con respecto a la salud de las mujeres, es importante centrarse en la acción contra la violencia doméstica, manteniendo la atención al ciclo embarazo-puerperal, la anticoncepción y las condiciones potencialmente graves, como las infecciones de transmisión sexual y el seguimiento oncológico

Universal health coverage as a global public health goal: the work of the International Labour Organisation, c. 1925-2018 / Cobertura universal como meta global de saúde pública: o trabalho da Organização Internacional do Trabalho, c. 1925-2018

Abstract We examine the efforts of the International Labour Organisation (ILO) to extend medical care under social security, through international conventions, advocacy and technical assistance. We consider the challenges faced by the ILO in advancing global health coverage through its labourist, social security model. The narrative begins in the interwar period, with the early conventions on sickness insurance, then discusses the rights-based universalistic vision expressed in the Philadelphia Declaration (1944). We characterize the ILO's postwar research and technical assistance as "progressive gradualism" then show how from the late-1970s the ILO became increasingly marginalized, though it retained an advisory role within the now dominant "co-operative pluralistic" model.

Resumo Analisamos os esforços da Organização Internacional do Trabalho (OIT) em ampliar o cuidado médico sob seguridade social, via convenções, amparo e assistência técnica internacionais. Consideramos os desafios da OIT no desenvolvimento da cobertura global de saúde por meio do modelo trabalhista e de seguridade social. A narrativa inicia no período entreguerras, com as primeiras convenções sobre seguro saúde, depois discute a visão universalista baseada em direitos da Declaração da Filadélfia (1944). Classificamos a pesquisa e a assistência da OIT no pós-guerra como "gradualismo progressivo" e mostramos como, a partir do final da década de 1970, a OIT foi marginalizada, embora mantivesse um papel de conselheira dentro do atual modelo "pluralista cooperativo" dominante.

Interlocuções entre a Declaração de Astana, o Direito à Saúde e a formação em Medicina de Família e Comunidade no Rio de Janeiro, Brasil / Dialogues between the Astana Declaration, the Right to Health and Family and Community Medicine training in Rio de Janeiro, Brazil

Resumo Este artigo discute e promove inquietações à luz da repercussão dos 40 anos da Declaração de Alma-Ata e também da Declaração de Astana, discutindo os possíveis impactos na formação em Medicina de Família e Comunidade, segundo o olhar de 2 Programas de Residência de 3 instituições públicas: a Universidade do Estado do Rio de Janeiro, a Universidade Federal do Rio de Janeiro e a Fundação Oswaldo Cruz. Estes estão inseridos em um contexto histórico e social, entre o mundo do trabalho, as políticas públicas, os organismos internacionais, a população e os sujeitos envolvidos na construção, manutenção e consolidação da Atenção Primária no Brasil. Assim, em um breve resgate histórico, contextualizamos qual Atenção Primária era cenário de prática e para onde, possivelmente, estaríamos nos deslocando. Conclui que a garantia do Direito à Saúde, estaria ameaçada pelo conceito de Cobertura Universal, preconizado pela Declaração de Astana; o que provoca importantes discussões: garantia de ofertas de serviços providos pelo estado, defesa da equidade e integralidade das ações. Reafirmação sobre o risco de gerar desigualdade ao se criar múltiplas ofertas de serviços para diferentes segmentos da população, reiteração sobre a importância do acesso às Unidades de Saúde, valorização da territorialização.

Abstract This paper discusses and fosters concerns in light of the repercussions of both the 40th anniversary of the Alma-Ata Declaration and the Astana Declaration, discussing the possible influence on Family and Community Medicine training, as per the lenses of two Residency Programs of three public institutions, namely, State University of Rio de Janeiro, Federal University of Rio de Janeiro, and the Oswaldo Cruz Foundation. These are inserted in a historical and social context, between the world of work, public policies, international organizations, the population and subjects involved in the construction, maintenance, and consolidation of the Brazilian PHC. Thus, in a brief historical revival, we contextualized which Primary Care was a practice setting and where we might be headed. We concluded that the willingness to ensure the Right to Health would be threatened by the concept of Universal Coverage, advocated by the Astana Declaration, which leads to essential discussions: ensuring state-provided services, advocating for equity and integrality of actions, reaffirming the risk of generating inequality by creating multiple service offerings for different segments of the population, reiterating the relevance of access to health, and valuation of territorialization.

Monitoramento e avaliação dos atributos da Atenção Primária à Saúde em nível nacional: novos desafios / Monitoring and evaluation of Primary Health Care attributes at the national level: new challenges

Resumo A partir da criação de uma Secretaria de Atenção Primária à Saúde (SAPS) no Ministério da Saúde em maio de 2019, cinco novos desafios foram trazidos para a gestão federal do SUS: a) ampliação do acesso da população às unidades de saúde da família, b) definição de um novo modelo de financiamento baseado em resultados em saúde e eficiência, c) definição de um novo modelo de provimento e formação de médicos de família e comunidade para áreas remotas, d) fortalecimento da clínica e do trabalho em equipe multiprofissional, e) ampliação da informatização das unidades de saúde e uso de prontuário eletrônico. Esse ensaio discute esses elementos à luz de um novo modelo avaliativo que, ao mesmo tempo, seja capaz de orientar o novo processo de financiamento da Atenção Primária à Saúde (APS) no Brasil. Este baseia-se na correção de distorções distributivas e também busca orientar maior efetividade e eficiência no investimento público e qualidade do serviço prestado à população. Através de estudos dos melhores exemplos internacionais e discussão com os representantes do Conselho Nacional de Secretários Estaduais de Saúde (CONASS) e do Conselho Nacional dos Secretários Municipais de Saúde (CONASEMS) e com apoio técnico do Banco Mundial, foi elaborada a proposta de novo modelo avaliativo e de financiamento da APS.

Abstract Five new challenges were brought to the federal management of SUS from the establishment of the Primary Health Care Secretariat (SAPS) in May 2019, as follows: a) to expand people's access to health facilities; b) to define a new financing model from health outcomes and efficiency; c) to define a new model of provision and training of family and community doctors for remote areas; d) to strengthen clinic and multi-professional teamwork; e) to expand computerization of health facilities and use of electronic medical records. This essay discusses these elements in light of a new evaluation model that also guides a new process of financing the Brazilian Primary Health Care (PHC). It builds on the correction of distributive distortions, and also seeks to guide greater effectiveness and efficiency in public investment and quality of service provided to the population. The proposal for a new PHC evaluation and financing model was elaborated through studies of the best international examples and discussion with representatives of the National Council of State Health Secretaries (CONASS) and the National Council of Municipal Health Secretaries (CONASEMS), and with technical support from the World Bank.

Pacientes com diabetes mellitus tipo 2 em uso de medicamentos via judicial: há monitorização clínica e laboratorial? / Patients with type 2 diabetes mellitus using drugs by filing lawsuits: is there clinical and laboratory monitoring? / Pacientes con diabetes mellitus tipo 2 en uso de medicamentos vía judicial: ¿hay monitoreo clínico y laboratorial?

Introdução: O aumento contínuo do número de processos de judicialização da saúde, a relevância epidemiológica do diabetes mellitus tipo 2 (DM2), a escassez de recursos utilizados para monitorar os investimentos dos processos judiciais e do seu alto custo para a saúde pública, diante disso torna-se necessário estudos que analisem o perfil da judicialização dos antidiabéticos, que é a principal classe de medicamentos alvo dos processos judiciais. Objetivo: Analisar se os pacientes com DM2 atendidos via judicial, foram acompanhados e monitorados no Sistema Único de Saúde (SUS) antes e após os processos judiciais. Além de analisar o perfil de medicamentos judicializados para tratamento da DM2. Métodos: Trata-se de um estudo longitudinal retrospectivo, que utilizou dados secundários, prontuários e arquivos de processos judiciais, de 56 pacientes com DM2 que adquiriram pelo menos um de seus medicamentos por meio da judicialização, no ano de 2019, em um município mineiro. Os dados foram analisados 12 meses antes e 12 meses após a judicialização. Resultados: Dentre as 56 ações judiciais, 39% se concentraram em apenas três unidades de saúde do município. Somente 30 pacientes (53%) antes e 29 (51%) após a judicialização tiveram consultas no SUS. Além disso, apenas 15 (26%) e 13 (23%) pacientes, respectivamente antes e após a judicialização, apresentaram algum exame laboratorial realizado pelo SUS. As insulinas Levemir Flex Pen® (13%), Novo Rapid® (11%) e Lantus® (7%) foram os medicamentos mais judicializados. Conclusão: Observou-se que apesar do SUS prover o insumo terapêutico de elevado custo por meio de uma porta de entrada não convencional, não há monitorização clínica e laboratorial para avaliação da efetividade do uso da tecnologia, conforme recomendam os protocolos clínicos e dispositivos legais brasileiros sobre acesso a medicamentos.

Introducción: El aumento continuo en el número de procesos de judicialización de la salud, la relevancia epidemiológica de la diabetes mellitus tipo 2 (DM2), la escasez de recursos utilizados para monitorear las inversiones en procesos judiciales y de su alto costo para la salud pública, se vuelven necesarios estudios que analicen el perfil de la judicialización de los antidiabéticos, que es la principal clase de medicamentos a las que se dirigen los procesos judiciales. Objetivo: Analizar si los pacientes con DM2 atendidos vía judicial, fueron acompañados y monitoreados en el Sistema Único de Salud (SUS) antes y después de los procesos judiciales. Además de analizar el perfil de las drogas legalizadas para el tratamiento de la DM2. Métodos: Se trata de un estudio retrospectivo longitudinal, que utilizó datos secundarios, registros médicos y archivos de demandas, de 56 pacientes con DM2 que adquirieron al menos uno de sus medicamentos a través de la judicialización, en el año 2019, en un municipio de Minas Gerais. Los datos fueron analizados 12 meses antes y 12 meses después de la judicialización. Resultados: Entre las 56 acciones judiciales, el 39% se concentró en solo tres unidades de salud en el municipio. Solo 30 pacientes (53%) antes y 29 (51%) después de la judicialización tuvieron consultas en el SUS. Además, solo 15 (26%) y 13 (23%) pacientes, respectivamente antes y después de la judicialización, se sometieron a pruebas de laboratorio realizadas por el SUS. Las insulinas Levemir Flex Pen® (13.0%), Novo Rapid® (11%) y Lantus® (7%) fueron los medicamentos más judicializadas. Conclusión: Se observó que a pesar de que el SUS proporciona un recurso terapéutico de alto costo a través de una puerta de entrada no convencional, no hay monitoreo clínico y laboratorial para la evaluación de la efectividad del uso de la tecnología, según lo recomendado por los protocolos clínicos y dispositivos legales brasileros sobre el acceso a medicamentos.

Introduction: The continuous increase in the number of health judicialization processes, the epidemiological relevance of type 2 diabetes mellitus (DM2), the scarcity of resources used to monitor the investments of lawsuits, and their high cost to public health, that said there is a need for studies that analyze the profile of the judicialization of antidiabetics, which is the main class of drugs targeted by lawsuits. Objective: To analyze whether patients with DM2 attended by judicial system, are followed up and monitored in Brazilian Public Health System (SUS) before and after judicial proceedings. In addition to analyzing the profile of drugs legalized for the treatment of DM2. Methods: A retrospective observational study, which secondary database, medical records and judicial files, was conducted with 56 patients with DM2 who have acquired at least one of their medicines through lawsuits, in 2019, in a city in Minas Gerais. The data were analyzed 12 months before and 12 months after judicialization process. Results: Among the 56 lawsuits, 39% were concentrated in only three health units. Only 30 patients (53%) before and 29 (51%) after judicialization had appointments in SUS. Furthermore, only 15 (26%) and 13 (23%) patients, respectively before and after judicialization, had some laboratory test performed by SUS. The insulins Levemir Flex Pen® (13%), Novo Rapid® (11%), and Lantus® (7%) were the most judicialized drugs. Conclusion: It was observed that despite the SUS providing the high-cost therapeutic input through an unconventional gateway, there is no clinical and laboratory monitoring to evaluate the effectiveness of the technology, as recommended by clinical protocols and Brazilian laws about access to medicines.

Serviços farmacêuticos na atenção primária à saúde: Estudo etnográfico em serviços de saúde no município de São Paulo / Pharmaceutical Services in Primary Health Care: Ethnographic Study in Health Services in the City of São Paulo

Os serviços farmacêuticos na Atenção Primária a Saúde (APS) é um tema emergente ao se tratar do contexto de desenvolvimento das políticas farmacêuticas no Brasil, em especial a de Assistência Farmacêutica. Na área, inúmeros estudos têm sido publicados e diversos grupos e instituições debatem o assunto, porém, sem um único consenso ou modelo propositivo. A APS ou Atenção Básica é o modelo de atenção prioritário adotado no Brasil, no SUS e tem como características a territorialização, o trabalho em equipe multiprofissional, o vínculo e o acolhimento. É um espaço rico de desenvolvimento de serviços farmacêuticos e de viabilidade das estratégias de garantia do direito à saúde, como o acesso a medicamentos essenciais e cuidado no seu uso. Por isso a farmácia na APS é um local de trabalho do farmacêutico, com boa empregabilidade e possibilidade de desenvolvimento de uma atuação não tão ligada a histórica formação do farmacêutico tecnicista. Além disso, é preciso desenvolver reflexões sobre serviços farmacêuticos utilizando dados da realidade, possibilitando que estudos como este possam contribuir no desenvolvimento de serviços na APS a partir das necessidades em saúde, considerando as determinações sociais do processo saúde-doença. Sendo assim, o objetivo desta tese foi o de caracterizar os serviços farmacêuticos na Atenção Primária à Saúde, no município de São Paulo, e como se expressam em diferentes modelos na materialidade da APS. Utilizou-se a pesquisa qualitativa, especificamente a Observação Participante, com abordagem etnográfica como fonte para o aprofundamento do conhecimento, pois permite a compreensão do homem em sua sociabilidade. O estudo foi desenvolvido no município de São Paulo. A primeira parte corresponde a um estudo exploratório, composto por um grupo focal com 20 farmacêuticos e um survey online aplicado a outros 120 farmacêuticos. Todos atuam na Secretaria Municipal de Saúde. Na segunda parte, o estudo foi desenvolvido em 3 Unidades Básicas de Saúde, com aproximadamente 170 horas de observação, registradas em cadernos de campo. Os registros possibilitaram a análise e a formação de categorias conceituais. Por fim, a APS permite uma construção e visão ampliadas do escopo dos serviços farmacêuticos, ao analisá-los a partir da percepção de quem os vive, uma vez que há o entendimento de que os serviços não são fragmentados e que o farmacêutico os executa em um campo complexo, ampliado e dinâmico como a APS. O uso da Observação Participante em estudos na área da saúde, especialmente na Farmácia, possibilita reflexões sobre o fenômeno, que não são isoladas, nem mesmo descontextualizadas da realidade em saúde. Identifica-se a necessidade de estudos qualitativos para a descrição interpretativa dos fenômenos na saúde apoiada nas ciências humanas, (re)fazendo movimentos de síntese críticos e reflexivos. Procedentes da análise, pode-se na observação participante compreender três modelos diferentes de atuação do farmacêutico, que geram concepções de serviços farmacêuticos distintas e que se relacionam aos modelos de APS, sendo alguns mais universais e integrais versus modelos de cobertura universal, focalizados e seletivos. Os serviços farmacêuticos na APS têm um potencial de compreender que as pessoas não são iguais por completo, e que é preciso reconhecer as necessidades e, por conseguinte, sociais. As evidências obtidas foram demonstradas em categorias conceituais relacionadas às diferentes perspectivas dos serviços farmacêuticos na APS, possibilitando entender que o farmacêutico é a referência em medicamentos nas UBS e tem-se feito essencial para a população, especialmente no campo da APS. Tendo nessa perspectiva uma nova prática, aquela que é real, construída pela prática da APS, e não em métodos teóricos de atendimento clínico. Os serviços farmacêuticos que se estabelecem na APS devem contribuir com as condições de vida, permeados pelo debate das determinações sociais de saúde, sendo necessário refletir sobre quais necessidades, àquelas vigentes e de acordo com o que o mercado deseja ou àquelas que correspondem as necessidades reais

Pharmaceutical services in Primary Health Care (PHC) is an emerging concept in the context of developing pharmaceutical policies in Brazil, especially Pharmaceutical Assistance. Numerous studies in this field have been published and several groups and institutions debate the subject; however, there is no consensus on the proposed model. PHC or Basic Care is the preferred model adopted in Brazil, in the Single Health System (SHS), and is characterized by territorialization, multiprofessional teamwork, relationships, and user embracement. It is a rich space for the development of pharmaceutical services and viable strategies for ensuring the right to health, including access to essential medicines and care in their use. That is why the pharmacy in PHC is a pharmacist's place of work, with good employability, and the possibility of developing an activity that goes beyond the traditional scope f a technical pharmacist. In addition, it is necessary to examine pharmaceutical services using actual data, enabling studies such as this to contribute to the development of PHC services based on health needs, considering the social determinants of the health-disease process. Thus, the objective of this thesis was to characterize the pharmaceutical services in PHC, in the city of São Paulo, and examine how they are expressed in different models in the materiality of PHC. We used qualitative research, specifically participant observation, with an ethnographic approach, to obtain in-depth knowledge, since it allows the understanding of man in his social context. The study was conducted in the city of São Paulo. The first part consists of an exploratory study, on a focus group with 20 pharmacists, and an online survey of another 120 pharmacists. They all work at the Municipal Health Office. The second part of the study was conducted in three Basic Health Units (BHU), with approximately 170 hours of observation recorded in field notebooks. The records made it possible to analyze and form conceptual categories. Finally, PHC allows a broader construct and vision of the scope of pharmaceutical services, by analyzing them from the perception of those who experience them, since there is an understanding that the services are not fragmented and that the pharmacist performs them in a complex, expanded, and dynamic field, like PHC. The use of participant observation in health field studies, especially in Pharmacy, allows reflections on the phenomenon, which are not isolated, nor decontextualized from the reality in health. The need for qualitative studies is felt for the interpretative description of health phenomena supported by the human sciences, (re)making critical and reflective synthesis movements., By using participant observation in the analysis, it is possible to understand three different models of the pharmacist's performance, which lead to distinct conceptions of pharmaceutical services and are related to PHC models, some of them more universal and integral compared to universal coverage models that are focused and selective. The pharmaceutical services in PHC have the potential to understand that people are not completely the same, and that it is necessary to recognize the needs, and therefore the social conditions. The evidence obtained has been demonstrated in conceptual categories related to the different perspectives of pharmaceutical services in PHC, making it possible to understand that the pharmacist is the authority in medicines at the Health Care Unit and has become essential for the population, especially in the field of PHC. This perspective comprises a new approach, one that is realistic and practical, built by the practice of PHC, and not based on theoretical methods of clinical care. The pharmaceutical services established in PHC must contribute to living conditions, accompanied by the debate on social health determinations, and it is necessary to reflect on which are the needs that are in force and according to what the market wants or those that correspond to real necessities

Reforms for financial protection schemes towards universal health coverage, Senegal

Advancing the public health insurance system is one of the key strategies of the Senegalese government for achieving universal health coverage. In 2013, the government launched a universal health financial protection programme, la Couverture Maladie Universelle. One of the programme's aims was to establish a community-based health insurance scheme for the people in the informal sector, who were largely uninsured before 2013. The scheme provides coverage through non-profit community-based organizations and by the end of 2016, 676 organizations had been established across the country. However, the organizations are facing challenges, such as low enrolment rates and low portability of the benefit package. To address the challenges and to improve the governance and operations of the community-based health insurance scheme, the government has since 2018 planned and partly implemented two major reforms. The first reform involves a series of institutional reorganizations to raise the risk pool. These reorganizations consist of transferring the risk pooling and part of the insurance management from the individual organizations to the departmental unions, and transferring the operation and financial responsibility of the free health-care initiatives for vulnerable population to the community-based scheme. The second reform is the introduction of an integrated management information system for efficient and effective data management and operations of the scheme. Here we discuss the current progress and plans for future development of the community-based health insurance scheme, as well as discussing the challenges the government should address in striving towards universal health coverage in the country

Purchasing reforms and tracking health resources, Kenya

As low- and middle-income countries undertake health financing reforms to achieve universal health coverage, there is renewed interest in making allocation of pooled funds to health-care providers more strategic. To make purchasing more strategic, countries are testing different provider payment methods. They therefore need comprehensive data on funding flows to health-care providers from different purchasers to inform decision on payment methods. Tracking funding flow is the focus of several health resource tracking tools including the System of Health Accounts and public expenditure tracking surveys. This study explores whether these health resource tracking tools generate the type of information needed to inform strategic purchasing reforms, using Kenya as an example. Our qualitative assessment of three counties in Kenya shows that different public purchasers, that is, county health departments and the national health insurance agency, pay public facilities through a variety of payment methods. Some of these flows are in-kind while others are financial transfers. The nature of flows and financial autonomy of facilities to retain and spend funds varies considerably across counties and levels of care. The government routinely undertakes different health resource tracking activities to inform health policy and planning. However, a good source for comprehensive data on the flow of funds to public facilities is still lacking, because these activities were not originally designed to offer such insights. We therefore argue that the methods could be enhanced to track such information and hence improve strategic purchasing. We also offer suggestions how this enhancement can be achieved

Changes in surgical practice in 85 South African hospitals during COVID-19 hard lockdown

Background. In preparation for the COVID-19 pandemic, South Africa (SA) began a national lockdown on 27 March 2020, and many hospitals implemented measures to prepare for a potential COVID-19 surge.Objectives. To report changes in SA hospital surgical practices in response to COVID-19 preparedness.Methods. In this cross-sectional study, surgeons working in SA hospitals were recruited through surgical professional associations via an online survey. The main outcome measures were changes in hospital practice around surgical decision-making, operating theatres, surgical services and surgical trainees, and the potential long-term effect of these changes.Results. A total of 133 surgeons from 85 hospitals representing public and private hospitals nationwide responded. In 59 hospitals (69.4%), surgeons were involved in the decision to de-escalate surgical care. Access was cancelled or reduced for non-cancer elective (n=84; 99.0%), cancer (n=24; 28.1%) and emergency operations (n=46; 54.1%), and 26 hospitals (30.6%) repurposed at least one operating room as a ventilated critical care bed. Routine postoperative visits were cancelled in 33 hospitals (36.5%) and conducted by telephone or video in 15 (16.6%), 74 hospitals (87.1%) cancelled or reduced new outpatient visits, 64 (75.3%) reallocated some surgical inpatient beds to COVID-19 cases, and 29 (34.1%) deployed some surgical staff (including trainees) to other hospital services such as COVID-19 testing, medical/COVID-19 wards, the emergency department and the intensive care unit.Conclusions. Hospital surgical de-escalation in response to COVID-19 has greatly reduced access to surgical care in SA, which could result in a backlog of surgical needs and an excess of morbidity and mortality

Towards universal quality health care through an independent accreditation agency: A review

Background@#Guaranteeing quality of health care services is part of the objectives of Republic Act No. 11223 or the Universal Health Care (UHC) Act of 2019. In assuring that quality services are delivered by health care providers, they must be accredited to participate in the National Health Insurance Program. The UHC Act mandates the Philippine Health Insurance Corporation (PhilHealth) to recognize third party mechanisms as basis of granting incentives for health facilities that deliver services of higher quality. This review aimed to identify lessons and experiences from literature that can be adopted and contextualized in the Philippine setting, for strategic policies on strengthening the national health facility accreditation system. @*Methods@#A systematic review of literature was conducted to generate evidence-based recommendations from discussions on cross country experiences and local government initiatives towards improved accreditation system. @*Results@#By virtue of the UHC Act, a form of strategic purchasing is further institutionalized through a rating system that incentivizes health facilities that provide better services in terms of quality, efficiency, and equity. It is imperative to consider the country’s previous and current gaps and challenges in accreditation and adopt the best practices of other countries, as appropriate to Philippine's local settings. A tool is proposed in creating a national hospital accreditation system using the domains of leadership and governance, financing and sustainability, standards development, program management, and continuing quality improvement. @*Conclusion and Recommendations@#With the legitimacy of third party accreditation body mandated by the UHC Act, operationalization of the prescribed mechanisms and organizational structure must enjoin all pertinent stakeholders and be supported by sustainable funds and technical assistance by the government.

Policy analysis on identifying copayment services for the shift in financing scheme of health care services

Background@#As the Philippines moves toward universal health coverage, it is imperative to examine how to eliminate inefficiencies, particularly misuse, overutilization, and risks of fraudulent claims. This position statement aimed to identify health services requiring copayments for cost-efficient health financing for the Universal Health Care Act. @*Methods@#A qualitative study was employed using a systematic review of literature, and thematic analysis of policy roundtable discussion (RTD) was conducted. The systematic review of literature generated evidence for the policy brief and critical points for discussion in the stakeholders’ RTD forum. The RTD was organized by the UP Manila Health Policy Development Hub (UPM HPDH) with the Department of Health (DOH) and was participated by key stakeholders of the policy issue to attain consensus recommendations and develop criteria for identifying services requiring copayments. @*Results@#An algorithm is proposed by the UPM HPDH based on collective expertise as a guide for policymakers to assess each benefit package in terms of overutilization, the danger of depleting government funds, and the risk of fraud. The use of clinical pathways is suggested to assess the misuse and overutilization of health services. In addition to copayments, benefits packages prone to fraudulent activities should be subjected to fraud prevention processes. Copayment should be linked inversely to the preventability level of the disease or condition. @*Conclusion@#There were gaps in the current policies to identify services requiring copayment services. Copayment schemes should be carefully determined to prevent misuse, overuse, and fraud of appropriate and necessary health services, while at the same time not limit access to needed care.

Rationalizing health personnel financing schemes for evidence-informed policy reforms: Policy analysis

Background@#The Universal Health Care Law seeks to optimize financing of personnel costs without compromising quality and equitable health care among the health care facilities. This position statement aimed to identify strategies and policy recommendations for the cost-effective financing of health personnel in public healthcare facilities. @*Methods@#A systematic review of literature was done to generate policy brief and key points for roundtable discussion in collaboration with the Department of Health (DOH). The discussion was guided by the three health financing options of DOH: (a) retain Personnel Services (PS) as DOH budget but shift Maintenance and Other Operating Expenses (MOOE) to PhilHealth; (b) shift PS and MOOE to PhilHealth, and (c) rationalize part-time status in government hospitals. @*Results@#The pros and cons of financing options were cross-examined. In Option 1, physicians in government hospitals would receive fixed salaries from DOH / Local Government Units. In Option 2, there would be a monopsony between PhilHealth and provincial power. Payment will be performance-driven, and balance billing will be eliminated. Option 3 would be a set up of retaining part-time positions for physicians. @*Conclusion and Recommendation@#Participants deduced that for Option 1, provision of salary augmentation sources and ensuring adequate plantilla items and level of remuneration in government hospitals should be considered, in order to sufficiently compete with physicians’ income from private practice. For Option 2, the PhilHealth reimbursement system should ensure timely reimbursement so as not to subject care providers to financial instabilities. For Option 3, rationalizing part-time status should be flexible and can be applied regardless of how physicians are paid, as this would incentivize caregivers to work harder and smarter.